1. Gangliosides are linked with Guillain Barré syndrome

   Newsletter Article 29 January 2013 Pages: 1 - 1

2. Clinical experience with sumatriptan indicates a favourable safety profile

   Newsletter Article 29 January 2013 Pages: 1 - 1

3. There may not be a time limit for the benefits of acetylcysteine in paracetamol overdose

   Newsletter Article 29 January 2013 Pages: 1 - 1

4. Aspirin and haemorrhagic stroke - is there a risk?

   Newsletter Article 29 January 2013 Pages: 2 - 2

5. The differences in susceptibility to anticonvulsant teratogenesis may be genetic

   Newsletter Article 29 January 2013 Pages: 2 - 2

6. Alcohol see Nicotinic acid interaction

   Newsletter Article 29 January 2013 Pages: 3 - 3

7. Antibacterials

   Newsletter Article 29 January 2013 Pages: 3 - 3

8. Anticonvulsants

   Newsletter Article 29 January 2013 Pages: 3 - 3

9. Aztreonam

   Newsletter Article 29 January 2013 Pages: 3 - 3

10. Benserazide see Levodopa + benserazide

    Newsletter Article 29 January 2013 Pages: 3 - 3

11. Bleomycin

    Newsletter Article 29 January 2013 Pages: 3 - 3

12. Carboplatin/cisplatin

    Newsletter Article 29 January 2013 Pages: 3 - 3

13. Chlorpromazine withdrawal

    Newsletter Article 29 January 2013 Pages: 3 - 3

14. Cisplatin

    Newsletter Article 29 January 2013 Pages: 3 - 3

15. Cisplatin see Carboplatin/cisplatin

    Newsletter Article 29 January 2013 Pages: 3 - 3

16. Cocaine abuse

    Newsletter Article 29 January 2013 Pages: 3 - 3

17. Dinoprost trometamol

    Newsletter Article 29 January 2013 Pages: 4 - 4

18. Ergocalciferol

    Newsletter Article 29 January 2013 Pages: 4 - 4

19. FK 506

    Newsletter Article 29 January 2013 Pages: 4 - 4

20. Fluorouracil

    Newsletter Article 29 January 2013 Pages: 4 - 4

21. Fluoxetine

    Newsletter Article 29 January 2013 Pages: 4 - 4

22. Fluoxetine withdrawal

    Newsletter Article 29 January 2013 Pages: 4 - 5

23. Gangliosides

    Newsletter Article 29 January 2013 Pages: 5 - 5

24. Gentamicin

    Newsletter Article 29 January 2013 Pages: 5 - 5

25. Heparin

    Newsletter Article 29 January 2013 Pages: 5 - 5

26. Ifosfamide

    Newsletter Article 29 January 2013 Pages: 5 - 5

27. Influenza virus vaccine

    Newsletter Article 29 January 2013 Pages: 5 - 5

28. Iron overdose

    Newsletter Article 29 January 2013 Pages: 5 - 5

29. Levodopa

    Newsletter Article 29 January 2013 Pages: 5 - 5

30. Levodopa + benserazide

    Newsletter Article 29 January 2013 Pages: 5 - 6

31. Lithium

    Newsletter Article 29 January 2013 Pages: 6 - 6

32. Mesalazine

    Newsletter Article 29 January 2013 Pages: 6 - 6

33. Methylprednisolone/pancuronium bromide

    Newsletter Article 29 January 2013 Pages: 6 - 6

34. Metronidazole

    Newsletter Article 29 January 2013 Pages: 6 - 6

35. Mifepristone

    Newsletter Article 29 January 2013 Pages: 6 - 7

36. Nicotinic acid interaction

    Newsletter Article 29 January 2013 Pages: 7 - 7

37. Nifedipine

    Newsletter Article 29 January 2013 Pages: 7 - 7

38. Oral contraceptives

    Newsletter Article 29 January 2013 Pages: 7 - 7

39. Pancuronium bromide see Methylprednisolone/pancuronium bromide

    Newsletter Article 29 January 2013 Pages: 7 - 7

40. Penicillamine

    Newsletter Article 29 January 2013 Pages: 7 - 7

41. Pentamidine

    Newsletter Article 29 January 2013 Pages: 7 - 7

42. Phenytoin

    Newsletter Article 29 January 2013 Pages: 7 - 8

43. Phenytoin overdose

    Newsletter Article 29 January 2013 Pages: 8 - 8

44. Propranolol

    Newsletter Article 29 January 2013 Pages: 8 - 8

45. Protamine sulfate

    Newsletter Article 29 January 2013 Pages: 8 - 8

46. Triazolam

    Newsletter Article 29 January 2013 Pages: 8 - 8